Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer

Notwithstanding the advances in the treatment of lung cancer with immune checkpoint inhibitors, the high percentage of non-responders supports the development of novel anticancer treatments. Herein, the expression of the onco-target nucleolin in patient-derived pulmonary carcinomas was characterized...

ver descrição completa

Detalhes bibliográficos
Autor principal: Fernandes, Ângela Valério (author)
Outros Autores: Fonseca, Nuno A. (author), Gonçalves, Nélio (author), Cruz, Ana F. (author), Pereira, Marta I. (author), Gregório, Ana C. (author), Moura, Vera (author), Ladeirinha, Ana F. (author), Alarcão, Ana (author), Gonçalves, Joana (author), Abrunhosa, Antero (author), Melo, Joana B. (author), Carvalho, Lina (author), Simões, Sérgio (author), Moreira, João N. (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
lung cancer
nucleolin expression
targeted intracellular drug delivery
tumor microenvironment
Texto completo:http://hdl.handle.net/10316/103212
País:Portugal
Oai:oai:estudogeral.sib.uc.pt:10316/103212

Texto Completo

http://hdl.handle.net/10316/103212

Registos relacionados